Sirolimus is effective for primary refractory/relapsed warm autoimmune haemolytic anaemia/Evans syndrome: a retrospective single-center study

Zhuxin ZhangDepartment of Hematology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Science, Beijing, ChinaView further author information

Qinglin HuDepartment of Hematology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Science, Beijing, ChinaView further author information

Chen YangDepartment of Hematology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Science, Beijing, ChinaView further author information

Miao ChenDepartment of Hematology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Science, Beijing, ChinaCorrespondence[email protected]
View further author information

Bing HanDepartment of Hematology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Science, Beijing, ChinaCorrespondence[email protected]

https://orcid.org/0000-0002-9717-217X View further author information

Sirolimus is effective for primary refractory/relapsed warm autoimmune haemolytic anaemia/Evans syndrome: a retrospective single-center study

Information for

Open access

Opportunities

Help and information

Sirolimus is effective for primary refractory/relapsed warm autoimmune haemolytic anaemia/Evans syndrome: a retrospective single-center study

Related research

To cite this article:

Download citation

Your download is now in progress and you may close this window

Login or register to access this feature

Information for

Open access

Opportunities

Help and information

Keep up to date